China Health Industries Holdings

What China Health Industries Holdings does

China Health Industries Holdings is a small, delisted Chinese pharmaceutical distribution and marketing company headquartered in Harbin, China, founded in 1996 and operating under the otcpink ticker CHHE. With only 11-50 employees and a generic business description focused on marketing and distributing high-quality medicines, the company appears to function as a regional medicine wholesaler rather than a manufacturer or vertically integrated pharma player. Governance is highly concentrated, with Sun Xin simultaneously serving as Chairman, CEO, CFO, and Treasurer, and no other executive team, board, or management data is disclosed.

Financial disclosures point to severe distress: revenue has trended sharply downward from 2019 through 2023, gross profit has collapsed, EBITDA and operating income are deeply negative, and net losses have persisted and widened in recent years. The company is delisted from a primary exchange, conducts no documented M&A, fundraising, product launches, or strategic partnerships, and shows no investments, regulatory actions, or restructuring events in the input record. The combination of micro-cap status, single-officer governance, delisting, and multi-year losses suggests a dormant or minimally operating entity rather than an active growth business.

Name

China Health Industries Holdings

Legal name

B52 Club

Website

https://chinahealthindustries.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

China Health Industries Holdings is a small, delisted Chinese pharmaceutical distributor headquartered in Harbin, founded in 1996, marketing and distributing medicines with 11-50 employees under consolidated leadership.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Pharmaceutical and Medicine Manufacturing (32541)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

Keywords

• Pharmaceutical distribution
• Medicine wholesale
• Drug marketing
• Healthcare products
• Pharmaceutical trading

Headquarters

HQ city

Harbin

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Gaming Transaction Fees: Platform generates revenue from gaming transactions including slot games, card games, fishing games, and mini-games. Players deposit money to play and platform retains margin from gameplay.
2. Promotional Redemption Programs: Revenue generated from player's net losses after accounting for promotional bonuses, cashback, and referral commissions paid out to users.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

China Health Industries Holdings is a for-profit company that markets and distributes high-quality medicines. The firm is headquartered in Harbin, China, and historically operated with a small workforce of 11-50 employees, suggesting a focused wholesale/trading role in the pharmaceutical supply chain.

Product overview

B52club is an online gaming and entertainment platform offering a comprehensive portfolio of gaming products. The platform operates as a unified mobile-optimized experience featuring six core product sections: card games (traditional Vietnamese games like Tiến lên, Phỏm, Mậu binh), slot games (2000+ titles with 3D graphics and progressive jackpots), fishing games (ocean-themed shooting games with multiplayer mode), mini games (quick-play Tài xỉu, xóc đĩa, bầu cua), international poker (Texas Hold'em with tournaments), and lottery games. The platform was established in 2018 and is operated by a Philippines-based entertainment technology group.

Differentiator

Problem solved

Functional benefit

Products and services

• High-quality Medicines

Quantifiable outcome

• Average RTP of 96%-98% on slot games
• +3 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• PG SoftcoreTechnology or IntegrationPG Soft provides slot game titles with RNG certification ensuring fair random outcomes. Their 3D slot games with attractive graphics are integrated into B52Club's platform.
• JILIcoreTechnology or IntegrationJILI provides slot and other game content with certified RNG ensuring random game results. Their game portfolio adds variety to B52Club's offerings.
• Pragmatic PlaycoreTechnology or IntegrationPragmatic Play supplies slot games and other gaming content with RNG certification. Their internationally recognized brand adds credibility to B52Club's game library.
• PAGCOR PhilippinescoreStrategic or Co-development PartnerPAGCOR (Philippine Amusement and Gaming Corporation) is the regulatory body providing gaming license and oversight for B52Club's online gambling operations in Southeast Asia.

Scale indicators4 records

Recent moves3 records

Broad incumbents

• Sinopharm Group: China's largest pharmaceutical distributor and wholesaler with national hospital and pharmacy network. Directly comparable as the dominant pharma distribution player serving the same end customers (hospitals, clinics, retailers) that China Health Industries targets, but at vastly greater scale.
• Shanghai Pharmaceuticals Holding: Major integrated pharmaceutical distributor and manufacturer listed in Hong Kong. Comparable as a top-tier Chinese pharma distributor serving hospital channels, offering a model of what scale operations look like in the same regulatory environment.
• China Resources Pharmaceutical Group: State-owned pharmaceutical distributor under China Resources conglomerate with extensive hospital distribution network. Directly comparable in business model (pharmaceutical distribution) and end customers, operating at much larger scale.

Direct peers

• Livzon Pharmaceutical Group: Integrated pharmaceutical manufacturer and distributor with established distribution network. Comparable as a Chinese pharmaceutical company combining product manufacturing with downstream distribution capabilities.
• Jointown Pharmaceutical Group: One of China's largest privately-controlled pharmaceutical distributors with national distribution network. Closely comparable as a mid-to-large scale pharmaceutical wholesaler targeting hospital and retail pharmacy channels.
• Yiling Pharmaceutical: Integrated pharmaceutical manufacturer and distributor with strong distribution capabilities in China. Comparable as a vertically integrated pharma company combining manufacturing with distribution channels, with similar exposure to Chinese hospital procurement reforms.
• China Traditional Chinese Medicine Holdings: Pharmaceutical company focused on TCM manufacturing and distribution. Comparable as a Hong Kong-listed Chinese pharma distributor exposed to the same hospital procurement and two-invoice regulatory framework.

Regional players

• Yifeng Pharmacy Chain: Major Chinese retail pharmacy chain operator purchasing from pharmaceutical distributors. Comparable as a downstream buyer in the same pharmaceutical supply chain, though operating in retail rather than wholesale distribution.
• Guangzhou Pharmaceutical Holdings: Major southern China pharmaceutical distributor with hospital channel focus. Comparable as a regional pharmaceutical distributor serving provincial hospital and retail pharmacy networks in a defined geographic territory.
• Nanjing Pharmaceutical: Regional pharmaceutical distributor based in eastern China serving hospital and pharmacy channels. Comparable as a sub-national pharmaceutical wholesaler with similar product mix and customer base to China Health Industries.

Market position

Strengths3 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights4 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about China Health Industries Holdings